Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001654954-25-012705
Filing Date
2025-11-07
Accepted
2025-11-07 16:31:11
Documents
18

Document Format Files

Seq Description Document Type Size
1 FORM S-3 cvm_s3.htm S-3 205163
2 SECURITIES PURCHASE AGREEMENT cvm_ex4.htm EX-4 120626
3 LEGAL OPINION cvm_ex5.htm EX-5 5950
4 CONSENT cvm_ex231.htm EX-23.1 2472
5 CONSENT cvm_ex232.htm EX-23.2 2587
6 FILING FEE TABLE cvm_ex107.htm   iXBRL EX-FILING FEES 25540
7 cvm_s3img2.jpg GRAPHIC 6544
  Complete submission text file 0001654954-25-012705.txt   491786

Data Files

Seq Description Document Type Size
21 EXTRACTED XBRL INSTANCE DOCUMENT cvm_ex107_htm.xml XML 4938
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

EIN.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: S-3 | Act: 33 | File No.: 333-291375 | Film No.: 251463115
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)